pipette
ENEnglish

HierDTA: Hierarchical Structure-Aware Representation Learning for Drug--Target Affinity Prediction

Huangchao Xu, Baohua Zhang, Qian Liu, Zhong Jin, Yi Du

Preprint con versión publicadaUso en el mundo real

En palabras de los autores

Drug--target affinity (DTA) prediction plays an important role in computer-aided drug discovery, where reliable computational models can help prioritize compound--protein pairs before experimental validation. A key challenge in DTA prediction is to effectively mine multi-level molecular information from drug structures while accurately modeling the binding-site environment of target proteins. To address these issues, we introduce HierDTA, a hierarchical structure-aware framework for DTA prediction. \textcolor{black}{HierDTA represents each drug as an atom--motif heterogeneous graph and introduces an augmentation module that propagates functional-motif semantics to the corresponding atoms. For proteins, kinase-domain structures are converted into residue interaction graphs. The resulting atom and residue representations are integrated using cross-attention to capture pair-specific relationships, while molecule fingerprints and pretrained ESM-2 embeddings provide complementary global information. Compared with state-of-the-art methods, HierDTA achieves superior performance on the Davis dataset across all metrics and attains the highest \(r_m^2\) of 0.791 on KIBA. It also exhibits strong generalization under cold-start settings, particularly on KIBA, where MSE is reduced by 21.7% in the unseen-protein scenario. Ablation study and interpretability analysis supported the contributions of the hierarchical augmentation and interaction components.} Case studies further showed that HierDTA provided early enrichment of candidate bioactive compounds. These results indicate that HierDTA is an effective framework for affinity prediction and target-specific virtual screening.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 21 de octubre. arXiv. Preprint con versión publicada.

DOI: 10.1021/acsomega.6c07956

Versión publicada: ACS Omega,2026

Comentario de los autores: 20 pages, 7 figures